The UK's developing landscape of consciousness-expanding substances is witnessing a remarkable shift, moving far beyond the traditional focus on those fungi and lysergic acid diethylamide. Attention is currently focused on lesser-known compounds, like dimethyltryptamine, CBG which is showing promise